The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAbrdn Di&g Regulatory News (ADIG)

Share Price Information for Abrdn Di&g (ADIG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 77.20
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 1.40 (1.813%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 77.20
ADIG Live PriceLast checked at -
Aberdeen Diversified Income & Growth is an Investment Trust

To target a total portfolio return of LIBOR (London Interbank Offered Rate) plus 5.5% p.a. (net of fees) over rolling five-year periods through investments from the widest range of asset classes.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Compliance with Market Abuse Regulation

3 May 2018 07:00

RNS Number : 7538M
Aberdeen Diversified I&G Trust PLC
03 May 2018
 

 

Aberdeen Diversified Income and Growth Trust plc

LEI - 2138003QINEGCHYGW702

 

3 May 2018

 

Aberdeen Diversified Income and Growth Trust plc (the "Company") announces that it is satisfied that any inside information which the Directors or the Company may have had up to today's date has previously been notified to a Regulated Information Service ("RIS").

 

By virtue of the points set out in (1) to (4) below, the Directors and the Company do not currently expect there to be any inside information arising in the closed period as defined by the EU Market Abuse Regulation. The closed period will end on the date of the announcement of the Company's Half-Yearly Financial Report for the six months ended 31 March 2018.

 

If, during the closed period leading up to the announcement of the Half-Yearly Financial Report, the Company or its Directors become aware of any inside information, such inside information will be managed in accordance with the UKLA's DTR 2.

 

The Company is therefore not prohibited from dealing in its own securities during the closed period.

 

1) the announcement on 6 April 2018 of the net asset value per share as of the close of business on 31 March 2018,

2) the Company's belief, following reasonable enquiries, that there will be no material difference between the information published on 6 April 2018 and that to be included in the forthcoming announcement of the Half-Yearly Financial Report,

3) the Company's practice of calculating net asset values per share each business day and the announcement of these net asset values to an RIS, and

4) there being no other unpublished information which constitutes price-sensitive information in respect of the Company's securities.

 

For further information, please contact:

 

Aberdeen Asset Management PLC

Secretaries

 

Tel. 0131 528 4000

 

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
CMCEAESFESFPEFF
Date   Source Headline
10th Mar 20232:33 pmRNSPortfolio disclosure
10th Mar 202312:36 pmRNSNet Asset Value(s)
9th Mar 20235:10 pmRNSTransaction in Own Shares
9th Mar 202312:31 pmRNSNet Asset Value(s)
8th Mar 20235:04 pmRNSTransaction in Own Shares
8th Mar 202311:40 amRNSNet Asset Value(s)
7th Mar 202312:15 pmRNSNet Asset Value(s)
6th Mar 20236:18 pmRNSMonth End Net Asset Value(s)
6th Mar 20235:10 pmRNSTransaction in Own Shares
6th Mar 20233:24 pmRNSGearing disclosure
6th Mar 202312:50 pmRNSNet Asset Value(s)
3rd Mar 20235:12 pmRNSTransaction in Own Shares
3rd Mar 202312:32 pmRNSNet Asset Value(s)
2nd Mar 20235:10 pmRNSTransaction in Own Shares
2nd Mar 20232:53 pmRNSNet Asset Value(s)
2nd Mar 20237:00 amRNSFirst Interim Dividend
1st Mar 20239:45 amRNSTotal Voting Rights
28th Feb 20234:32 pmRNSResult of AGM
28th Feb 202312:33 pmRNSNet Asset Value(s)
27th Feb 20235:01 pmRNSTransaction in Own Shares
27th Feb 20232:04 pmRNSGearing disclosure
27th Feb 202312:35 pmRNSNet Asset Value(s)
24th Feb 20235:19 pmRNSTransaction in Own Shares
24th Feb 20231:32 pmRNSNet Asset Value(s)
23rd Feb 20235:23 pmRNSTransaction in Own Shares
23rd Feb 202311:41 amRNSNet Asset Value(s)
22nd Feb 202311:37 amRNSNet Asset Value(s)
21st Feb 202310:58 amRNSNet Asset Value(s)
20th Feb 20235:25 pmRNSTransaction in Own Shares
20th Feb 20231:35 pmRNSGearing disclosure
20th Feb 202312:37 pmRNSNet Asset Value(s)
17th Feb 20235:03 pmRNSTransaction in Own Shares
17th Feb 202312:34 pmRNSNet Asset Value(s)
16th Feb 20235:03 pmRNSTransaction in Own Shares
16th Feb 202312:07 pmRNSNet Asset Value(s)
15th Feb 20235:05 pmRNSTransaction in Own Shares
15th Feb 202311:31 amRNSNet Asset Value(s)
14th Feb 20235:19 pmRNSTransaction in Own Shares
14th Feb 20234:06 pmRNSPortfolio disclosure
14th Feb 202312:28 pmRNSNet Asset Value(s)
13th Feb 20233:48 pmRNSGearing disclosure
13th Feb 202312:29 pmRNSNet Asset Value(s)
10th Feb 20234:55 pmRNSTransaction in Own Shares
10th Feb 202312:41 pmRNSNet Asset Value(s)
9th Feb 20235:22 pmRNSTransaction in Own Shares
9th Feb 20231:05 pmRNSNet Asset Value(s)
8th Feb 20235:11 pmRNSTransaction in Own Shares
8th Feb 20231:24 pmRNSNet Asset Value(s)
7th Feb 20235:07 pmRNSTransaction in Own Shares
7th Feb 20231:28 pmRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.